Robert Mark Minutello, M.D.

Interventional Cardiology
Robert Minutello

The art of medicine is always a collective effort - in order for a physician to provide optimal medical care, he or she must be surrounded and supported by the optimal team. Weill Cornell has afforded me the opportunity to work in such an environment and provide the finest of medical care. Moreover, my dual role as provider and educator allows me to train and mentor the brightest of future physicians."

 

Dr. Minutello is an Interventional Cardiologist specializing in angioplasty and stenting, as well as management of cardiovascular diseases on an outpatient basis. His areas of research interest include percutaneous coronary intervention outcomes research and he is in charge of the Cornell Cath Lab institutional database. Dr. Minutello has worked jointly with the New York State Department of Health in outcomes data analysis utilizing the statewide angioplasty registry.

Dr. Minutello is the Director of the Interventional Cardiology Training program at Weill Cornell. He serves on the Institutional Review Board as well as the institution's Acute Coronary Syndrome/Door to Balloon committee.

A summary of Dr. Minutello's Education, Training and/or Faculty Appointments is listed as following:

1991   B.S. - Brown University

1996   M.D. - Washington University, St. Louis

1999   Residency, Internal Medicine - Cornell Medical College

2002   Fellowship, Cardiology - Cornell Medical College

2003   Fellowship, Interventional Cardiology - Cornell Medical College

Other: Fellow, American College of Cardiology

              Fellow, Society for Cardiovascular Angiography and Interentions

              Associate Professor of Medicine, Weill Cornell Medical Center

              Director, Interventional Cardiology Fellowship Training Program

Insurances

Insurance Plans Accepted

The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please feel free to contact this physician or this physician's practice as they may have individual contracts not included on this site.

  • AETNA [HMO]
  • AETNA [PPO]
  • AETNA [Medicare]
  • Aetna - Weill Cornell [POS]
  • Affinity Essential
  • Affinity Health Plan
  • Blue Priority Network
  • CIGNA
  • Emblem Select Care
  • Empire Blue Cross/Blue Shield [Pathway X]
  • Empire Blue Cross/Blue Shield [Pathway X Enhanced]
  • Empire Blue Cross/Blue Shield [PPO]
  • Empire Blue Cross/Blue Shield [EPO]
  • Empire Blue Cross/Blue Shield [HMO]
  • Empire Blue Cross/Blue Shield [Mediblue (Senior)]
  • Fidelis Care
  • GHI [CBP]
  • Health First
  • Health Insurance Plan of NY (HIP) [Medicare]
  • Health Insurance Plan of NY (HIP)
  • Health Insurance Plan of NY (HIP) [Medicaid]
  • Health Plus - Amerigroup [CHP]
  • Health Plus - Amerigroup
  • Health Republic
  • Medicare [Medicare]
  • Oscar
  • Oxford Health Plans [Liberty]
  • Oxford Health Plans [Medicare Advantage]
  • Oxford Health Plans [Freedom]
  • POMCO
  • Rockefeller University - CoreSource
  • UHC Compass
  • United Empire
  • United Health Care
  • United Health Care [Medicare]
  • United Health Care [Community Plan]
  • VNSNY CHOICE Medicare [Medicare]
  • VNSNY CHOICE Medicare [HMO]

Publications

ORIGINAL ARTICLES HH Ho, R Minutello, N Juliano, SC Wong. A Rare Cause of Acute Myocardial Infarction: Thrombotic Thrombocytopenic Purpura. Int J Cardiol. 2007 Dec 6. RM Minutello, S Bhagan, A Sharma, AJ Slotwiner DN Feldman, LJ Cuomo, SC Wong. Long-Term Clinical Benefit of Sirolimus-Eluting Stents Compared to Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease. J Interv Cardiol. 2007; 20:458-65. DN Feldman, CL Gade, AJ Slotwiner, M Parikh, G Bergman, SC Wong, RM Minutello. Impact of Bivalirudin on Outcomes Following Percutaneous Coronary Revascularization with Drug-Eluting Stents. Am Heart Journal 2007; 154:695-701. DN Feldman, RM Minutello, CL Gade, SC Wong. Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry). Am J Cardiol. 2007;99:446-9. DN Feldman, CL Gade, AJ Slotwiner, M Parikh, G Bergman, SC Wong, RM Minutello, New York State Angioplasty Registry. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry). Am J Cardiol. 2006; 98:1334-9. F Yang, RM Minutello, S Bhagan, A Sharma, SC Wong. The impact of gender on vessel size in patients with angiographically normal coronary arteries. J Interv Cardiol. 2006;19:340-4. Z Khurram, E Chou, R Minutello, G Bergman, M Parikh, S Naidu, SC Wong, MK Hong. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol. 2006; 18:162-4. RM Minutello, S Bhagan, D Feldman, A Sharma, MK Hong, S Chiu Wong. Angiographic Pattern of Restenosis Following Implantation of Overlapping Sirolimus-Eluting (Cypher) Stents. Am Jour Cardiology, 2006; 97:499-501. JA Kong, ET Chou, RM Minutello, SC Wong, MK Hong. Safety of single versus multi-vessel angioplasty for patients with acute myocardial infarction and multi-vessel coronary artery disease: report from the New York State Angioplasty Registry. Coron Artery Dis. 2006;17:71-5. RM Minutello, ET Chou, MK Hong, S Chiu Wong. Impact of Race and Ethnicity on In-Hospital Outcomes Following Percutaneous Coronary Intervention (Report from the 2000-2001 New York State Angioplasty Registry). Am Heart J. 2006; 151:164-7. SC Wong, RM Minutello, MK Hong. Neurological Complications Following Percutaneous Coronary Interventions (A Report from the 2000–2001 New York State Angioplasty Registry). Am Jour Cardiology. 2005;96: 1248-1250. RM Minutello, ET Chou, MK Hong, M Parikh, G Bergman, F Iacovone, SC Wong. Impact of Body Mass Index on In-Hospital Outcomes Following Percutaneous Coronary Intervention (Report From the New York State Angioplasty Registry). Am Jour Cardiology. 2004;93:1229–1232 ET Chou, RM Minutello, M Parikh, G Bergman, S Chiu Wong, MK Hong. Can we identify vulnerable patients at risk for ST-segment elevation myocardial infarction based on their clinical characteristics? Coron Artery Dis. 2004;15:467-9. RM Minutello. Drugs for Percutaneous Coronary Interventions. The Medical Letter on Drugs and Therapeutics. 2004;46:100-2. RM Minutello. Drug-Eluting Stents. The Medical Letter on Drugs and Therapeutics. 2003;45:23-24

Honors and Awards

Missouri Medical Association Award (1996)